This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (10) Citing Articles via Google Scholar Google Scholar Articles by Zahn, R. Search for Related Content PubMed PubMed Citation Articles by Zahn, R.

CLINICAL RESEARCH: INTERVENTIONAL CARDIOLOGY

Embolic Protection Devices for Carotid Artery Stenting

Is There a Difference Between Filter and Distal Occlusive Devices?

Ralf Zahn, MD, FESC^_*,_*, Thomas Ischinger, MD, FESC, Bernd Mark, MD^_*, Sabine Gass, MD, Uwe Zeymer, MD, FESC^_*, Wolfgang Schmalz, MD, Klaus Haerten, MD^||, Karl Eugen Hauptmann, MD^¶, Enz-Rüdiger von Leitner, MD^#, Wolfgang Kasper, MD^_**, Ulrich Tebbe, MD, FESC, Jochen Senges, MD, FACC, FESC^_* for the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)

^_* Herzzentrum, Kardiologie, Ludwigshafen
Städtisches Klinikum, Kardiologie, München-Bogenhausen
Städtisches Klinikum, Neurologie, Ludwigshafen
Stadtkrankenhaus, Kardiologie, Worms
^|| Marienkrankenhaus, Kardiologie, Wesel
^¶ Krankenhaus der Barmherzigen Brüder, Kardiologie, Trier
^# Klinikum Siloah, Kardiologie, Hannover
^_** St. Josefs Hospital, Kardiologie, Wiesbaden
Klinikum Lippe-Detmold, Kardiologie, Detmold, Germany

Manuscript received December 16, 2004; revised manuscript received February 12, 2005, accepted February 22, 2005.

^_* Reprint requests and correspondence: Dr. Ralf Zahn, Herzzentrum Ludwigshafen, Dept. of Cardiology, Bremserstrasse 79, D-67063 Ludwigshafen, Germany. (Email: erzahn{at}aol.com).

OBJECTIVES: We sought to compare the efficacy of a filter embolic protection device (F-EPD) and a distal occlusive embolic protection device (DO-EPD) in patients undergoing carotid artery stenting (CAS).

BACKGROUND: The embolic protection device (EPD) may lower the periprocedural rate of cerebral ischemic events during CAS. However, it is unclear whether there is a difference in effectiveness between the different types of EPD.

METHODS: We analyzed data from the Carotid Artery Stent (CAS) Registry.

RESULTS: From July 1996 to July 2003, 1,734 patients were included in the prospective CAS Registry. Of these patients, 729 patients were treated with an EPD, 553 (75.9%) with F-EPD, and 176 (24.1%) with DO-EPD. Patients treated with DO-EPD were more likely to be treated for symptomatic stenosis (64.5% vs. 53.4%, p = 0.011). The carotid lesions in patients treated under DO-EPD seemed to be more complicated, as expressed by a higher proportion of ulcers (p = 0.035), severe calcification (p = 0.039), a longer lesion length (p = 0.025), and a higher pre-interventional grade of stenosis (p < 0.001). The median duration of the CAS intervention was 30 min in the DO-EPD group, compared with 48 min in the filter group (p < 0.001). No differences in clinical events rate between the two groups of protection devices were observed. Multivariate analysis on the occurrence of the combined end point of in-hospital death or stroke found no difference between filter- and DO-EPD (4 of 176 [2.3%] for DO-EPD vs. 10 of 551 [1.8%] for F-EPD; adjusted odds ratio = 1.04, 95% confidence interval 0.24 to 4.44; p = 0.958).

CONCLUSIONS: Filter EPD is the currently preferred method of EPD in clinical practice. Both F-EPD and DO-EPD seem to be equally effective during CAS.

Abbreviations and Acronyms   ALKK = Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte   CAS = carotid artery stenting   CEA = carotid endarterectomy   CI = confidence interval   DO-EPD = distal occlusive embolic protection device   EPD = embolic protection device   F-EPD = filter embolic protection device   OR = odds ratio

This article has been cited by other articles:

				E. Mahmud, J. J. Cavendish, and A. Salami Current Treatment of Peripheral Arterial Disease: Role of Percutaneous Interventional Therapies J. Am. Coll. Cardiol., August 7, 2007; 50(6): 473 - 490. [Abstract] [Full Text] [PDF]

				F. Asakura, K. Kawaguchi, H. Sakaida, N. Toma, S. Matsushima, K. Kuraishi, H. Tanemura, Y. Miura, M. Maeda, and W. Taki Diffusion-weighted MR imaging in carotid angioplasty and stenting with protection by the reversed carotid arterial flow. AJNR Am. J. Neuroradiol., April 1, 2006; 27(4): 753 - 758. [Abstract] [Full Text] [PDF]